- ICH GCP
- US Clinical Trials Registry
- Search trials
Example: Heart Attack
Clinical Trials on Meningeal Neoplasms
Total 254 results
-
NCT05895344Not yet recruitingCavernous Sinus Meningioma | Proton-therapy | Photon Radiotherapy | Cognitive and Functional Impact
-
NCT05832099Not yet recruiting
-
NCT05821790Not yet recruiting
-
NCT05809752RecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Leptomeningeal Disease
-
NCT05805631Not yet recruitingCarcinoma, Non-Small-Cell Lung | Leptomeningeal Metastasis | Epidermal Growth Factor Receptor
-
NCT05800275Not yet recruitingBreast Cancer Metastatic | Leptomeningeal Metastasis
-
NCT05793034RecruitingMeningioma | Anaplastic Meningioma | Meningioma Atypical
-
NCT05793489RecruitingBrain Metastases, Adult
-
NCT05746754Not yet recruitingLeptomeningeal Metastasis
-
NCT05727605RecruitingGlioma | Pituitary Adenoma | Brain Tumor | Magnetic Resonance Imaging | Meningioma | Cognition
-
NCT05639491RecruitingPetrous Apex Meningioma
-
NCT05630664RecruitingHigh Grade Glioma | High Grade Meningioma
-
NCT05598853RecruitingMelanoma Stage IV | Leptomeningeal Metastasis | Non-small Cell Lung Cancer Stage IV
-
NCT05576103RecruitingGlioma | Meningioma | Primary Brain Tumor | Schwannoma
-
NCT05537675Not yet recruitingRefractory Meningioma
-
NCT05497076Not yet recruitingNon-small Cell Lung Cancer Confirmed by Histopathology or Cytology | The TNM (8th) Phase is IV | With EGFR Mutations | Meningeal Progression Occurred After Previous Platinum-containing Two-drug Chemotherapy and Third-generation EGFR-TKI Treatment | Male or Female | The Age of 18 Years Old or More | ECOG PS 0 to 2 Points
-
NCT05425004Recruiting
-
NCT05414123RecruitingBreast Cancer | Non-Small Cell Lung Cancer | Leptomeningeal Disease | Leptomeningeal Metastasis | Leptomeningeal Neoplasms
-
NCT05385185RecruitingLeptomeningeal Metastasis | Immune Checkpoint Inhibitor | Endostatin
-
NCT05305885RecruitingLeptomeningeal Metastasis
-
NCT05305378Not yet recruitingAneurysm, AVM, Dural Arteriovenous Fistula, Glioma, Meningioma, Metastasis, Bypass
-
NCT05278208RecruitingHigh Grade Glioma | Medulloblastoma | Meningioma | Anaplastic Ependymoma | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Refractory Malignant Glioma | Refractory Medulloblastoma | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Primary Central Nervous System Neoplasm
-
NCT05259332Recruiting
-
NCT05254197RecruitingPituitary Adenoma | Meningioma | Schwannoma | Brain Tumor, Primary | Gliomas Benign
-
NCT05230381RecruitingMeningioma | Tranexamic Acid | Intraoperative Blood Loss
-
NCT05184816RecruitingLeptomeningeal Metastases
-
NCT05146219RecruitingNSCLC | Brain Metastases | EGFR Activating Mutation | Leptomeningeal Metastasis
-
NCT05139277Not yet recruitingGlioblastoma | Meningioma | Brain Metastases | Schwannoma | Pituitary Tumor | Glial Tumor
-
NCT05130866Recruiting
-
NCT05112549Recruiting
-
NCT05081908RecruitingMeningioma Atypical
-
NCT05034497RecruitingLeptomeningeal Metastasis
-
NCT05023018RecruitingResidual, Progressive or Recurrent Grade II or III Meningioma
-
NCT04997317Recruiting